Search Results - "Jaller Raad, Juan José"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Fracture risk assessment in Latin America: is Frax™ an adaptable instrument for the region by Morales-Torres, Jorge, Clark, Patricia, Delezé-Hinojosa, Margarita, Cons-Molina, Fidencio, Messina, Osvaldo Daniel, Hernández, Jaime, Jaller-Raad, Juan José, Quevedo-Solidoro, Héctor, Radominski, Sebastiao Cezar

    Published in Clinical rheumatology (01-10-2010)
    “…Osteoporosis is a generalized disease of bone that increases fracture risk. Multiple factors influence this risk, besides low bone mass. To decrease…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double‐Blind, Phase II Trial by Cohen, Stanley, Zhao, Rui, Toth, Balazs, Hackney, Jason A., Berman, Alberto, Chinn, Leslie W., Genovese, Mark C., Berman, Alberto, Porto, Alejandro, Granel, Amelia, Asnal, Cecilia, Moreno, Jose Luis Cristian, Gulin, Juan Pablo, Hofman, Julio, Ulla, Maria Rosa, Sabelli, Mirtha, Mannucci, Pablo Alejandro, Melazzi, Ana Cláudia Cauceglia, Scotton, Antônio Scafuto, Funes, Elisete, Gimenez, Emerson Alves, Marcolino, Flora Maria D’Andrea, Neto, João Francisco Marques, Keiserman, Mauro Waldemar, Radominski, Sebastião Cézar, Lima, Sônia Maria Alvarenga Anti Loduca, Pavan, Thaís Rohde, Ivanova, Delina, Penev, Dimitar, Dimitrov, Emil, Kapandjieva, Nadezhda, Aleksieva, Tanya, Tsvetanova, Tanya, Popova, Valentina, Spasov, Yuliy, Arteaga Unigarro, Carlos Ernesto, Raad, Juan Jose Jaller, Lee, Chang Keun, Lee, Eun Young, Lee, Sang‐Heon, Kang, Seong Wook, Lee, Yun Jong, Torres, Isaura Rodriguez, Ceceña, Marco Maradiaga, Hernandez, Miguel Cortes, Zielinska, Agnieszka, Dudek, Anna, Rychlewska‐Hanczewska, Anna, Racewicz, Artur, Stasiuk, Barbara, Jeka, Slawomir, Lowenhoff, Tomasz, Rebrov, Andrey, Vinogradova, Irina, Ler, Irina, Savina, Ludmila, Stanislav, Marina, Sandin, Mikhail, Zyablova, Natalia, Mosesova, Nino, Polovnikova, Oksana, Nesmeyanova, Olga, Samigullina, Ruzana, Moiseev, Sergey, Raskina, Tatiana, Popova, Tatiana, Ristic, Gorica, Damjanov, Nemanja, Ostojic, Predrag, Yagensky, Andriy, Gnylorybov, Andriy, Rekalov, Dmytro, Gasanov, Iurii, Nadashkevych, Oleg, Yatsyshyn, Roman, Smiyan, Svitlana, Vizir, Vadym, Kachur, Victoria, Tseluyko, Vira, Povoroznyuk, Vladyslav, Koshlia, Volodymyr, Zhdan, Vyacheslav, Lymar, Yurii, Mostovoy, Yuriy, Hawkes, Angela, Mabaquiao, Arthur, Scoville, Craig, Wyatt, David, Weinstein, Debra, McIlwain, Harris, Poiley, Jeffrey, Dao, Kathryn, Turner, Mark, Genovese, Mark, Borofsky, Michael, Waller, Philip, Metyas, Samy, Shroff, Sharukh, Cohen, Stanley, Syed, Tauseef

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-09-2020)
    “…Objective To evaluate fenebrutinib, an oral and highly selective noncovalent inhibitor of Bruton's tyrosine kinase (BTK), in patients with active rheumatoid…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty‐Four–Month, Phase III Study by Heijde, Désirée, Strand, Vibeke, Keystone, Edward, Kremer, Joel, Cardiel, Mario H., Cohen, Stanley, Nash, Peter, Song, Yeong‐Wook, Gruben, David, Fleischmann, Roy, Hall, Stephen, Nicholls, David, Baker, Milton F., Bessette, Louis, Haraoui, Boulos, Khraishi, Majed, Thorne, J., Birbara, Charles Allen, Baraf, Herbert Stuart Block, Bathon, Joan Marie, Brodsky, Alan Lawrence, Cush, John Joseph, Fleischmann, Roy Mitchell, Halter, Dale George, Hargrove, Jody Kay, Bouda, David William, Reddy Pasya, Suresh Kumar, Hill, Geneva Louise, Jackson, Raymond Edward, Kafka, Shelly Pearl, Kaine, Jeffrey Louis, Kempf, Kevin James, Kolba, Karen Sue, Longley, Selden, Mathews, Steven D., Misischia, Richard James, Niemer, Mark William, Palmer, William Rodney, Sayers, Michael Eugene, Schuette, Patrick Thomas, Shergy, William Julius, Sikes, David Hilton, Silverfield, Joel Charles, Taborn, James D., Wells, Alvin Francis, Wolfe, Sanford Mayer, Adhikari, Prabha, Amano, Kouichi, Bae, Sang‐Cheol, Chandrashekara, Srikantiah, Chopra, Arvind K., Hsu, Ping‐Ning, Iwahashi, Mitsuhiro, Kadel, Jugal Kishore, Kawabe, Yojiro, Koh, Eun‐Mi, Lan, Joung‐liang, Lin, Hsiao‐Yi, Liou, Lieh‐bang, Liu, Ming‐Fei, Miyasaka, Nobuyuki, Mori, Shunsuke, Park, Sung‐Hwan, Rao, Uppuluri Ramakrishna, Shim, Seung Cheol, Shobha, Vineeta, Takasaki, Yoshinari, Takeuchi, Tsutomu, Tanaka, Yoshiya, Tohma, Shigeto, Tsai, Wen‐Chan, Veeravalli, Sarath Chandra Mouli, Wagh, Shrikant, Yamanaka, Hisashi, Bichoversuska, Daniela, Goranov, Ivan, Hrytsenko, Halyna M., Kopackova, Jana, Oparanov, Boycho, Petrov, Andriy, Pokrzywnicka‐Gajek, Ines, Povoroznyuk, Vladyslav V., Ruzga, Zofia, Stanislavchuk, Mykola A., Tseluyko, Vira Iosypivna, Vitek, Petr, Freitas Zerbini, Cristiano Augusto, Cardiel‐Rios, Mario H., Escalante, William Jose Otero, Maldonado‐Lopez, Maria Concepcion, Jaller Raad, Juan Jose, Hernandez, Javier Dario Marquez, Jauregui, Edwin Antonio, Keiserman, Mauro W., Melazzi, Ana Claudia Cauceglia, Pascual‐Ramos, Virginia, Pinto, Luciana Teixeira, Radominski, Sebastiao C., Ximenes, Antonio Carlos, Morales, Sol Villegas

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-06-2019)
    “…Objective Tofacitinib is an oral JAK inhibitor for the treatment of rheumatoid arthritis (RA). The phase III, 24‐month, placebo‐controlled Oral Rheumatoid…”
    Get full text
    Journal Article
  8. 8